David M. Bronson - Jun 1, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M. Oliker for David M. Bronson by Power of Attorney
Stock symbol
CNMD
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/2/2022, 09:12 PM
Previous filing
Jun 3, 2021
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +812 +5.82% $0.00 14.8K Jun 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -812 -100% $0.00* 0 Jun 1, 2022 Common Stock 812 $0.00 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +3.45K $0.00 3.45K Jun 1, 2022 Common Stock 3.45K $111.79 Direct F2
transaction CNMD Rsus (restricted Stock Units) Award $0 +335 $0.00 335 Jun 1, 2022 Common Stock 335 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.